Saudi insurers are facing a widening profitability gap as claim costs outpace premium growth, prompting a debate over whether owning parts of the healthcare delivery chain could improve margins.
Profitability gap widens despite market growth
According to a recent analysis, the five largest private healthcare providers in Saudi Arabia recorded operating margins ranging from 16% to 22% between 2016 and 2024, comfortably above the global average of 16%. In contrast, the country’s five biggest health insurers posted margins that swung from a 4% loss to a 6% profit, settling around 5% in 2024, below the 7% global benchmark.
The market itself continues to expand. Projections indicate that Saudi Arabia’s health and medical insurance sector will grow at an annual rate of 6%, reaching roughly $16.12 billion by 2031 from $11.41 billion in 2026. More than 70% of premiums come from group policies sold to employers, highlighting the sector’s reliance on corporate customers.
Rising costs strain insurers
Cost pressures are mounting. A report highlighted GLP‑1 obesity drugs as an emerging claim driver, adding an estimated $800 million (SAR 3 billion) in annual expenses. Regulatory caps on premium increases further limit insurers’ ability to keep pace with medical inflation.
Fraud, waste, and abuse are also significant factors. The analysis estimated that these issues account for between 10% and 12% of total claims, eroding profitability even further.
Rather than relying solely on repricing, insurers are exploring ownership of healthcare assets. A 2019 amendment to Saudi Arabia’s Private Health Institutions law now permits insurers to own clinics, diagnostic centres, and hospitals. The two largest insurers have already begun moving into delivery.
Experts suggest a cautious approach. They recommend starting with consultation and diagnostic services because they require less capital while still allowing insurers to influence referrals and treatment decisions.
Telehealth is another avenue.
Insurers are increasingly bundling insurance with remote medical services, aiming to manage costs and stay competitive.
For patients, this shift could mean more integrated care pathways, though the impact on choice and pricing remains uncertain.
What ownership could mean for margins
If insurers acquire diagnostic facilities, they may capture a larger share of the value chain without the heavy investment hospitals demand. This could tighten the margin spread between payers and providers, though the exact effect depends on execution and regulatory oversight.
However, owning hospitals entails higher capital requirements and operational complexities, potentially exposing insurers to new risks. The balance between cost control and service quality will be a key factor in determining whether such vertical integration delivers the expected financial benefits.
In practice, the move toward ownership reflects a broader trend of insurers seeking diversified revenue streams amid rising medical costs. The strategy may help stabilize profits, but it also raises questions about market concentration and the long‑term effects on consumer choice.